Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: Effect of route of inoculation on immune response

Vaccine

Volumn 19, Issue 2-3, 2000, Pages 253-263

  Mittal, Suresh K ^a   Aggarwal, Neeraj ^a   Sailaja, G ^a   Van Olphen, Alberto ^a   Hogenesch, Harm ^a   North, Adam ^a   Hays, John ^b   Moffatt, Stanley ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Adenovirus; Biodegradable microsphere; DNA immunization; Gene delivery vehicle; Mucosal immune response; Systemic immune response

Indexed keywords

ALGINIC ACID; DNA VACCINE; IMMUNOGLOBULIN G; MICROSPHERE; PLASMID DNA;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BIODEGRADATION; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0034666728     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00170-5     Document Type: Article

References (49)

1. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
2. Ulmer J.B. Elegantly presented DNA vaccines. Nat. Biotechnol. 15:1997;842-843.
3. Donnelly J.J., Ulmer J.B., Liu M.A. DNA vaccines. Life Sci. 60:1997;163-172.
4. Felgner P.L. Nonviral strategies for gene therapy. Sci. Am. 276:1997;102-106.
5. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
6. Zenke M., Steinlein P., Wagner E., Cotten M., Beug H., Birnstiel M.L. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc. Natl. Acad. Sci. USA. 87:1990;3655-3659.
7. Cotten M., Wagner E., Zatloukal K., Phillips S., Curiel D.T., Birnstiel M.L. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA. 89:1992;6094-6098.
8. Yang N.S., Burkholder J., Roberts B., Martinell B., McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA. 87:1990;9568-9572.
9. Williams R.S., Johnston S.A., Riedy M., DeVit M.J., McElligott S.G., Sanford J.C. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci. USA. 88:1991;2726-2730.
10. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
11. Felgner P.L., Ringold G.M. Cationic liposome-mediated transfection. Nature. 337:1989;387-388.
12. Barthel F., Remy J.S., Loeffler J.P., Behr J.P. Gene transfer optimization with lipospermine-coated DNA. DNA Cell Biol. 12:1993;553-605.
13. Demeneix B.A., Abdel-Taweb H., Benoist C., Seugnet I., Behr J.P. Temporal and spatial expression of lipospermine-compacted genes transferred into chick embryos in vivo. Biotechniques. 16:1994;496-501.
14. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414.
15. Degano P., Sarphie D.F., Bangham C.R. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. Vaccine. 16:1998;394-398.
16. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:1999;387-391.
17. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C., Greenberg H.B., Herrmann J.E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:1998;5757-5761.
18. Bowersock T.L., Hogenesch H., Suckow M., Porter R.E., Jackson R., Park H., Park K. Oral vaccination with alginate microsphere systems. J. Control Release. 39:1996;209-220.
19. Bowersock T.L., Hogenesch H. Oral immunization using microparticles. Park K. Controlled drug delivery challenges and strategies. 1997;269-288 American Chemical Society, Washington.
20. Bowersock T.L., HogenEsch H., Suckow M., Guimond P., Martin S., Borie D., Torregrosa S., Park H., Park K. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine. 17:1999;1804-1811.
21. Hilbert A.K., Fritzsche U., Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine. 17:1999;1065-2073.
22. Periwal S.B., Speaker T.J., Cebra J.J. Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates. J. Virol. 71:1997;2844-2850.
23. Aggarwal N., HogenEsch H., Guo P., North A., Suckow M., Mittal S.K. Biodegradable alginate microspheres as a delivery system for naked DNA. Can. J. Vet. Res. 63:1999;148-152.
24. Yoshimura K., Rosenfeld M.A., Seth P., Crystal R.G. Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors. J. Biol. Chem. 268:1993;2300-2303.
25. Curiel D.T., Agarwal S., Wagner E., Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. USA. 88:1991;8850-8854.
26. Cotten M., Wagner E., Birnstiel M.L. Receptor-mediated transport of DNA into eukaryotic cells. Methods Enzymol. 217:1993;618-644.
27. Graham F.L., Prevec L. Manipulation of adenovirus vectors. Murray E.J. Methods in molecular biology: gene transfer and expression protocols. vol. 7:1991;109-128 The Humana Press, Clifton.
28. Addison C.L., Hitt M., Kunsken D., Graham F.L. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78:1997;1653-1661.
29. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
30. Mittal S.K., Middleton D.M., Tikoo S.K., Babiuk L.A. Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology. 213:1995;131-139.
31. Davis H.L., Whalen R.G., Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene. Ther. 4:1993;151-159.
32. Norman J.A., Hobart P., Manthorpe M., Felgner P., Wheeler C. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine. 15:1997;801-803.
33. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., Robinson H.L., Santoro J.C., Fuller J.T., Widera G., Haynes J.R., Purcell R.H., Davis H.L. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol. Med. 5:1999;287-300.
34. Gramzinski R.A., Millan C.L., Obaldia N., Hoffman S.L., Davis H.L. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol. Med. 4:1998;109-118.
35. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
36. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
37. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:1997;4591-4601.
38. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:1997;3138-3145.
39. Lillard J.W. Jr., Boyaka P.N., Hedrick J.A., Zlotnik A., McGhee J.R. Lymphotactin acts as an innate mucosal adjuvant. J. Immunol. 162:1999;1959-1965.
40. Ulmer J.B., DeWitt C.M., Chastain M., Friedman A., Donnelly J.J., McClements W.L., Caulfield M.J., Bohannon K.E., Volkin D.B., Evans R.K. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine. 18:(1/2):1999;18-28.
41. Lillie J.W., Green M.R. Transcription activation by the adenovirus E1A protein. Nature. 338:(6210):1989;39-44.
42. Shenk T., Flint J. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Can. Res. 57:1991;47-85.
43. Fuller D.H., Simpson L., Cole K.S., Clements J.E., Panicali D.L., Montelaro R.C., Murphey-Corb M., Haynes J.R. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol. Cell Biol. 75:1997;389-396.
44. Caver T.E., Lockey T.D., Srinivas R.V., Webster R.G., Hurwitz J.L. A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation. Vaccine. 17:1999;1567-1572.
45. Hartmann G., Weiner G.J., Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA. 96:1999;9305-9310.
46. Brazolot Millan C.L., Weeratna R., Krieg A.M., Siegrist C.A., Davis H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA. 95:1998;15553-15558.
47. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1128.
48. Casares S., Inaba K., Brumeanu T.D., Steinman R.M., Bona C.A. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186:1997;1481-1486.
49. Daheshia M., Kuklin N., Manickan E., Chun S., Rouse B.T. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine. 16:1998;1103-1110.